ASNR 2026-2027 Election Candidates — Executive Council Member-At-Large

Jeremy J. Heit, MD, PhD
ASNR Executive Council Member-At-Large Nominee

Brief Biosketch:
I grew up in Colorado, and I attended the University of Colorado at Boulder between ski trips. I then completed my medical and graduate school training (MD and PhD) at Stanford University. After medical school, I moved to the Boston for an internal medicine internship at the Brigham and Women’s Hospital followed by a diagnostic radiology residency at Massachusetts General Hospital (MGH). During my time at MGH, I served as Chief Resident in Radiology, and I completed a year of sub-specialty diagnostic neuroradiology training. After completing my diagnostic radiology training, I returned to Stanford for a two-year neurointerventional radiology (NIR) fellowship. After completion of my NIR fellowship, I was recruited to join the faculty at Stanford. I have been on the Stanford faculty for a decade, and I am currently a Professor of Radiology and, by courtesy, of Neurosurgery at Stanford, the Chief of Neuroimaging and Neurointervention, and the Stanford NIR fellowship director.

I run an active research group, and our team has contributed substantially to the imaging of acute ischemic stroke and thrombectomy treatment of ischemic stroke patients. In addition, my group develops new minimally invasive, image-guided treatments for ischemic stroke, including thrombectomy devices and robotic approaches for neurointervention. I have authored over 275 publications, and I am have been a key investigator on multiple NIH-grants, including the CRISP 2 and DEFUSE 3 studies. I am currently the co-PI of the NIH-funded PRECISE basilar thrombectomy study and the OUTER LIMITS large core thrombectomy trial.

My service to NIR, neuroradiology, and radiology extends beyond Stanford. I have served as a radiology representative on the Society of Neurointerventional Surgery as the membership committee chair, as co-chair of the annual SNIS fellows’ course (2020 and 2021), as the co-chair of the SNIS Annual Meeting (2022), and on the SNIS Board of Directors as the Member at Large (Radiology), and the Education Chair (2023-2024). I am currently serving as the Treasurer for SNIS.  I also serve on several other national committees with the American Board of Neurological Surgeons (CAST and RFP committees), the American Society of Neuroradiology, and the Radiological Society of North America among others. My service to ASNR extends over more than a decade. I have served on the Research Committee, the Standards Committee, and as a member of the Neurointerventional Counsel. I have enjoyed serving on the annual meeting committee as a planner of the NIR sessions and as an annual abstract reviewer.

Statement of Goals:
If elected as Member-at-Large, I would work to maintain an active interest in NIR among neuroradiologists. NIR is wonderfully multidisciplinary, but neurointerventionalists are continually pulled further and further away from our neuroradiology home base as the field evolves. We must intentionally work to integrate NIR physicians into neuroradiology, share image-guided treatment decision making in NIR with our diagnostic colleagues, and continue to advance both NIR and neuroradiology through collaboration. NIR physicians also have much to offer to diagnostic neuroradiologists, as NIR doctors are internal referring MDs with a lot of insight to issues and challenges faced by those who rely on neuroimaging for treatment of their patients on both an emergent and elective basis.

ASNR has long been a wonderful source of education for our members and trainees. I would additionally work to bolster further the NIR educational content at our annual meeting and through our society educational efforts, such as the ASNR webinar series. These educational venues offer an opportunity to extend NIR education to our members and beyond, as well as help to recruit promising young physicians into our specialty.

In summary, I am honored to be nominated for the ASNR Member-at-Large position. Thank you for your consideration, and I look forward to working with all of our ASNR members to continue to promote our marvelous field.

Steve Hetts, MD, FACR
ASNR Executive Council Member-At-Large Nominee

Brief Biosketch:
Steven Hetts, MD, FACR is Professor of Radiology, Biomedical Imaging, and Neurological Surgery, Co-Chief of the Neuro Endovascular Surgery Division at UCSF, where he provides interventional neuroradiology services for children and adults with stroke, cerebrovascular disease and tumors. A graduate of Harvard College and Harvard Medical School, Dr. Hetts completed his medical internship at Stanford, diagnostic radiology residency, diagnostic neuroradiology fellowship, and interventional neuroradiology fellowship at UCSF where he joined the faculty in 2008. He was honored by his colleagues in 2017 with the UCSF Exceptional Physician Award for his compassionate care of children with complex neurovascular conditions.

Dr. Hetts is the founding Co-Director of the UCSF Hereditary Hemorrhagic Telangiectasia Center of Excellence in which he collaborates with specialists from over a dozen other disciplines to provide comprehensive care for families with autosomal dominant genetic vascular malformations of the brain, lung, liver, aerodigestive tract and other organs. He received the Robert I. White Young Clinician Award for Outstanding Contributions to HHT Care, by Cure HHT in 2017. HHT is a complex condition that lends itself to diagnosis and management by radiologists. To improve upon current HHT MRI, CT, and US imaging protocols (formalized in an international consensus panel co-led by Dr. Hetts in 2019-2020), Dr. Hetts serves as principal investigator of the DoD-supported AVIATOR study that uses ferumoxytol to image AVMs of the brain, lung, and liver all in a single MRI examination.

As Co-Director of the UCSF Interventional Radiology Research Laboratory, Dr. Hetts also develops novel medical devices. He and his colleagues have invented chemotherapy toxicity-reducing endovascular ChemoFilters. Developed with the support of the National Cancer Institute R01 and STTR programs as well as most recently with NIBIB R01 support for real-time PET imaging of drug distribution throughout the body during intra-arterial drug administration, these ChemoFilters promise to increase the efficacy of chemotherapy while reducing side effects. First-in-man studies are being planned by Filtro, a startup company spun out of UCSF to commercialize these devices.

An active member of the Academic Senate, Dr. Hetts served as faculty representative to the UC Regents Health Services Committee from 2018-2020 and Chair of the UCSF Division of the Academic Senate from 2023-2025. He also serves on the Academic Advisory Board of the UC National Center for Free Speech and Public Engagement. During his chairmanship of the Committee on Academic Personnel, the promotions committee for the UCSF campus, Dr. Hetts partnered with academic administrators to adopt policies keeping faculty on track for on-time promotions during the disruptions of the COVID-19 pandemic.

Statement of Goals
Throughout my career, I have been deeply involved in ASNR and other radiology professional organizations. As a member of ACR since 2001, a senior member of ASNR since 2005, and a senior member of SNIS since 2008, I have worked to elevate the voice of neuroradiology in patient care, research, and in health policy both within the house of radiology and more broadly with colleagues in and outside of medicine.

Much of my work has been in developing standards and guidelines and practice parameters for our field that enhance the rigor of our clinical practice. Having chaired both the SNIS and ASNR Standards and Guidelines Committees, I have been proud to contribute to the publication of some of the most highly-cited reports on practice standards in our field in JNIS and — more recently with the support of Max Wintermark and John Jordan — in AJNR. I have served as the Senior Editor of the busy Neurointerventional Section of AJNR since 2023. Emphasizing the value brought by neuroradiologists in the delivery of medical care enhances our professional standing and acknowledges our essential roles improving patients’ lives.

I would be honored to serve as Member-At-Large for the ASNR Executive Council during a time of rapid technological change and policy challenges. When I was a neuroradiology fellow, we went into endovascular stroke treatment cases expecting therapeutic failure. Twenty years later — with an armamentarium of new imaging techniques, endovascular devices, rapid triage pathways, CPT codes, MS-DRGs, and other policy changes to support large vessel occlusion stroke treatment — we expect success for our patients. Attending to all the elements required both in our field and well beyond it, neuroradiologists can transform care for many other neurologic conditions. To do that, we must stay professionally engaged and train the next generation to be similarly innovative and collaborative. I would bring those values to the Member-At-Large role and humbly ask for your support.